BridgeMD
New treatment option for Hereditary Malignant Neoplasm
Official title Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer Syndromes
ClinicalTrials.gov ID: NCT06927947
What this study is testing
- What it's testing
- This clinical trial tests whether various web-based tools can help improve communication about hereditary cancer risk in families and decrease barriers to genetic testing for relatives of patients with hereditary cancer syndromes. Between 5% and 10% of all cancers are caused by genetic changes that are hereditary, which means that they run in families.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- PROBANDS: Clinically confirmed autosomal dominant pathogenic germline variant (PGV) associated with a hereditary cancer syndrome
- PROBANDS: Previous evaluation by the University of Michigan (U-M) Cancer Genetics Clinic
- PROBANDS: ≥ 18 years old
- PROBANDS: Able to speak and read English
- PROBANDS: Access to the internet
You likely can't join if
- RELATIVES: Prior clinical germline genetic testing for cancer or already have an upcoming appointment scheduled with a genetics provider, per...
See the full eligibility criteria
- PROBANDS: Clinically confirmed autosomal dominant pathogenic germline variant (PGV) associated with a hereditary cancer syndrome
- PROBANDS: Previous evaluation by the University of Michigan (U-M) Cancer Genetics Clinic
- PROBANDS: ≥ 18 years old
- PROBANDS: Able to speak and read English
- PROBANDS: Access to the internet
- RELATIVES: Biological relative of proband
- RELATIVES: ≥ 18 years old
- RELATIVES: Able to speak and read English
- RELATIVES: Access to the internet
- RELATIVES: Have not completed germline genetic testing, per self-report at baseline
- RELATIVES: Prior clinical germline genetic testing for cancer or already have an upcoming appointment scheduled with a genetics provider, per self-report at baseline
The study team makes the final eligibility decision.
Where it's taking place
- Ann Arbor, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ann Arbor, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.